Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Ultragenyx Germany GmbH, Rahel-Hirsch-Str. 10, 10557 Berlin, Germany
Evkeeza 150 mg/ml concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Concentrate for solution for infusion (sterile concentrate). Clear to slightly opalescent, colourless to pale yellow sterile solution with a pH of 6.0 and an osmolality of approximately 500 mmol/kg. |
Each ml of concentrate for solution for infusion contains 150 mg of evinacumab.
One vial of 2.3 ml of concentrate contains 345 mg of evinacumab.
One vial of 8 ml of concentrate contains 1,200 mg of evinacumab.
Evinacumab is produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.
For the full list of excipients, see section 6.1
| Active Ingredient | Description | |
|---|---|---|
| Evinacumab |
Evinacumab is a recombinant human monoclonal antibody, which specifically binds to and inhibits ANGPTL3. ANGPTL3 is a member of the angiopoietin-like protein family that is expressed primarily in the liver and plays a role in the regulation of lipid metabolism by inhibiting lipoprotein lipase (LPL) and endothelial lipase (EL). |
| List of Excipients |
|---|
|
Proline |
2.3 ml of concentrate in a 3 ml clear Type 1 glass vial with a grey chlorobutyl stopper with coating and a seal cap with a flip-off button containing 345 mg of evinacumab. Pack size of 1 vial.
8 ml of concentrate in a 20 ml clear Type 1 glass vial, with a grey chlorobutyl stopper with coating and a seal cap with a flip-off button containing 1,200 mg of evinacumab. Pack size of 1 vial.
Not all pack sizes may be marketed.
Ultragenyx Germany GmbH, Rahel-Hirsch-Str. 10, 10557 Berlin, Germany
Date of first authorisation: 17 June 2021
| Drug | Countries | |
|---|---|---|
| EVKEEZA | Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
